Journal article icon

Journal article

Prolyl-4-hydroxylase 3 maintains β cell glucose metabolism during fatty acid excess in mice

Abstract:
The α-ketoglutarate–dependent dioxygenase, prolyl-4-hydroxylase 3 (PHD3), is an HIF target that uses molecular oxygen to hydroxylate peptidyl prolyl residues. Although PHD3 has been reported to influence cancer cell metabolism and liver insulin sensitivity, relatively little is known about the effects of this highly conserved enzyme in insulin-secreting β cells in vivo. Here, we show that the deletion of PHD3 specifically in β cells (βPHD3KO) was associated with impaired glucose homeostasis in mice fed a high-fat diet. In the early stages of dietary fat excess, βPHD3KO islets energetically rewired, leading to defects in the management of pyruvate fate and a shift from glycolysis to increased fatty acid oxidation (FAO). However, under more prolonged metabolic stress, this switch to preferential FAO in βPHD3KO islets was associated with impaired glucose-stimulated ATP/ADP rises, Ca(2+) fluxes, and insulin secretion. Thus, PHD3 might be a pivotal component of the β cell glucose metabolism machinery in mice by suppressing the use of fatty acids as a primary fuel source during the early phases of metabolic stress
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1172/jci.insight.140288

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-8996-5102
More by this author
Role:
Author
ORCID:
0000-0001-8399-1281
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-3572-4669
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-4173-7837
More by this author
Role:
Author
ORCID:
0000-0003-3901-0479


More from this funder
Funder identifier:
https://ror.org/03x94j517
Grant:
MR/N00275X/1,MR/S025618/1
More from this funder
Funder identifier:
10.13039/100010269
Grant:
104612/Z/14/Z).
More from this funder
Funder identifier:
10.13039/501100000289
Grant:
C42109/A26982,C42109/A24891
More from this funder
Funder identifier:
10.13039/501100000274
Grant:
FS/15/56/31645
More from this funder
Funder identifier:
10.13039/501100000361
Grant:
17/0005681


Publisher:
American Society for Clinical Investigation
Journal:
JCI Insight More from this journal
Volume:
6
Issue:
16
Pages:
e140288
Article number:
e140288
Publication date:
2021-07-15
DOI:
EISSN:
2379-3708
ISSN:
2379-3708


Language:
English
Keywords:
Pubs id:
1186963
Local pid:
pubs:1186963
Source identifiers:
W3182785939
Deposit date:
2026-03-25
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP